Atovaquone dosage and administration: Difference between revisions
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Atovaquone}} {{CMG}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEPRON (ATOVAQUONE) SUSPENSION [GLAXOSMITHKLINE LLC] | url =ht...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Dosage and Administration== | |||
====Dosage==== | |||
Prevention of PCP: Adults and Adolescents (13 to 16 Years) | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEPRON (ATOVAQUONE) SUSPENSION [GLAXOSMITHKLINE LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b426b6bf-f07e-4580-97ae-dfca1ddf5b8f | publisher = | date = | accessdate = }}</ref> | The recommended oral dose is 1,500 mg (10 mL) once daily administered with a meal. | ||
Treatment of Mild-to-Moderate PCP: Adults and Adolescents (13 to 16 Years) | |||
The recommended oral dose is 750 mg (5 mL) administered with meals twice daily for 21 days (total daily dose 1,500 mg). | |||
Note: Failure to administer MEPRON Suspension with meals may result in lower plasma atovaquone concentrations and may limit response to therapy (see CLINICAL PHARMACOLOGY and PRECAUTIONS). | |||
====Administration==== | |||
Foil Pouch | |||
Open pouch by removing tab at perforation and tear at notch. Take entire contents by mouth. Can be discharged into a dosing spoon or cup or directly into the mouth. | |||
Bottle | |||
SHAKE BOTTLE GENTLY BEFORE USING.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEPRON (ATOVAQUONE) SUSPENSION [GLAXOSMITHKLINE LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b426b6bf-f07e-4580-97ae-dfca1ddf5b8f | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 01:29, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosage and Administration
Dosage
Prevention of PCP: Adults and Adolescents (13 to 16 Years)
The recommended oral dose is 1,500 mg (10 mL) once daily administered with a meal.
Treatment of Mild-to-Moderate PCP: Adults and Adolescents (13 to 16 Years)
The recommended oral dose is 750 mg (5 mL) administered with meals twice daily for 21 days (total daily dose 1,500 mg).
Note: Failure to administer MEPRON Suspension with meals may result in lower plasma atovaquone concentrations and may limit response to therapy (see CLINICAL PHARMACOLOGY and PRECAUTIONS).
Administration
Foil Pouch
Open pouch by removing tab at perforation and tear at notch. Take entire contents by mouth. Can be discharged into a dosing spoon or cup or directly into the mouth.
Bottle
SHAKE BOTTLE GENTLY BEFORE USING.[1]
References
Adapted from the FDA Package Insert.